Clinical Trial Update: Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for moxifloxacin ophthalmic solution in bacterial conjunctivitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Moxifloxacin AF Ophthalmic Solution (moxifloxacin)

Snippet

Sponsor: Alcon Research | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2011-03-22